Table 3 TRAEs within 100 days after ASCT in CEAC, BEAM and IEAC groups.
Adverse events* grade 3–4 | CEAC group n = 28 | BEAM group n = 14 | IEAC group n = 10 | P value |
---|---|---|---|---|
Infection | 10 (35.7%) | 9 (64.3%) | 4 (40.0%) | 0.252 |
Oral mucositis | 4 (14.3%) | 3 (21.4%) | 3 (30%) | 0.458 |
Cardiotoxicity‡ | 2 (7.1%) | 0 (0.0%) | 1 (10.0%) | 0.583 |
Liver damage | 2 (7.1%) | 0 (0.0%) | 0 (0.0%) | 0.704 |